+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance model



Comprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance model



Plos One 8(5): E64422



Moraxella catarrhalis is one of the three most common causative bacterial pathogens of otitis media, however no effective vaccine against M. catarrhalis has been developed so far. To identify M. catarrhalis vaccine candidate antigens, we used carefully selected sera from children with otitis media and healthy individuals to screen small-fragment genomic libraries that are expressed to display frame-selected peptides on a bacterial cell surface. This ANTIGENome technology led to the identification of 214 antigens, 23 of which were selected by in vitro or in vivo studies for additional characterization. Eight of the 23 candidates were tested in a Moraxella mouse pulmonary clearance model, and 3 of these antigens induced significantly faster bacterial clearance compared to adjuvant or to the previously characterized antigen OmpCD. The most significant protection data were obtained with the antigen MCR_1416 (Msp22), which was further investigated for its biological function by in vitro studies suggesting that Msp22 is a heme binding protein. This study comprises one of the most exhaustive studies to identify potential vaccine candidate antigens against the bacterial pathogen M. catarrhalis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269971

Download citation: RISBibTeXText

PMID: 23671716

DOI: 10.1371/journal.pone.0064422


Related references

Immunization with the truncated adhesin moraxella catarrhalis immunoglobulin D-binding protein (MID764-913) is protective against M. catarrhalis in a mouse model of pulmonary clearance. Journal of Infectious Diseases 190(2): 352-355, 2004

Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model. Infection and Immunity 75(6): 2818-2825, 2007

Moraxella CD outer membrane protein elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of Moraxella catarrhalis in a mouse model. 2007

Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model. Journal of Infectious Diseases 178(6): 1667-1675, 1998

Nasopharyngeal clearance of Moraxella catarrhalis in a mouse model. Abstracts of the General Meeting of the American Society for Microbiology 102: 172, 2002

Pulmonary clearance of Moraxella catarrhalis in an animal model. Journal of Infectious Diseases 165(4): 644-650, 1992

Outer-membrane antigen expression by Moraxella (Branhamella) catarrhalis influences pulmonary clearance. Journal of Medical Microbiology 47(2): 159-168, 1999

Effect of immunization on pulmonary clearance of Moraxella catarrhalis in an animal model. Journal of Infectious Diseases 168(2): 469-472, 1993

A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infection and Immunity 61(5): 2003-2010, 1993

Pili play an important role in enhancing the bacterial clearance from the middle ear in a mouse model of acute otitis media with Moraxella catarrhalis. Pathogens and Disease 67(2): 119-131, 2013

Intranasal immunization with detoxified lipooligosaccharides from Moraxella catarrhalis conjugated to a protein elicit protection in a mouse model of colonization. Abstracts of the General Meeting of the American Society for Microbiology 101: 302, 2001

Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model. Infection and Immunity 75(4): 1778-1784, 2006

Evaluation of detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins as a vaccine in an aerosol challenge mouse model. Abstracts of the General Meeting of the American Society for Microbiology 100: 300, 2000

Immune enhancement of pulmonary clearance of moraxella catarrhalis. Abstracts of the General Meeting of the American Society for Microbiology 92: 80, 1992

Investigation of mucosal immunisation in pulmonary clearance of Moraxella (Branhamella) catarrhalis. Vaccine 18(5-6): 398-406, 1999